---  
layout: startup_page  
title: "Ratio Therapeutics"  
id: "ratiotx.com"  
permalink: "/ratiotherapeuticsratiotx.com01172024/"  
website: "https://www.ratiotx.com/"  
funding_round: "Series B"  
funding_amount: "$50M"  
investors: "Schusterman, Duquesne, PagsGroup, Bristol Myers Squibb, Center for Technology Licensing at Cornell University"  
about: "Ratio Therapeutics is a pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment and monitoring. They utilize proprietary technologies, Trillium and Macropa, to create novel radiopharmaceuticals targeting high unmet needs in solid tumors. This approach addresses challenges in delivery, safety, and efficacy of traditional radiopharmaceuticals."  
markets: "Pharmaceuticals, Oncology, Radiopharmaceuticals, Biotechnology, Life Science, Medical"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/ratio-therapeutics"  
twitter: "https://twitter.com/Ratio_Tx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/ratio-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/498227-86"  

date_display: "17-Jan-2024"  
date: "2024-01-17"

# SEO Optimization  
meta_title: "Ratio Therapeutics - Series B Funding ($50M)"  
meta_description: "Ratio Therapeutics, Ratio Therapeutics is a pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment and monitoring. They utilize proprie..."  
meta_keywords: "Ratio Therapeutics, Pharmaceuticals, Oncology, Radiopharmaceuticals, Biotechnology, Life Science, Medical, Series B funding"  
canonical_url: "https://startup.projectstartups.com/ratiotherapeuticsratiotx.com01172024/"  
---